# Takeshi Nakamura

> Takeshi is a postdoctoral researcher developing novel cyclic peptide therapeutics targeting previously undruggable cancer proteins. His library screening technology has generated significant interest from pharmaceutical companies.

*Source: [https://selltoscientists.com/phd/takeshi-nakamura/](https://selltoscientists.com/phd/takeshi-nakamura/)*

**Institution:** University of Tokyo
**Field:** Drug Discovery
**Advisor:** Dr. Hiroaki Suga
**Thesis:** Macrocyclic peptide libraries for targeting protein-protein interactions in oncology
**Publications:** 9

## Skills

- Medicinal Chemistry
- High-Throughput Screening
- Mass Spectrometry
- Molecular Docking
- Python
- Biochemical Assays

## Industry transition signals

- Published industry-focused review
- Attended JP Morgan Healthcare Conference
- Joined university tech transfer committee

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product